U.S. flag An official website of the United States government
  1. Home
  2. For Health Professionals
  3. COVID-19 Health Care Professional Resources
  1. For Health Professionals

COVID-19 Health Care Professional Resources


COVID-19 News for Health Care Professionals

Vaccine News

Therapeutics News

Testing News

  • FDA revised the emergency use authorizations (EUAs) of all COVID-19 antigen tests: Repeat or serial testing (11/1/2022)

  • FDA issued an EUA for the first over-the-counter molecular test authorized for use with saliva specimens (10/18/2022)

  • Jiangsu Well Biotech Co., Ltd. recalls COVID-19 Ag Rapid Test Devices that are not authorized, cleared, or approved by the FDA (10/12/2022)

  • FDA updates COVID-19 test policy, encourages developers to seek traditional premarket review (9/27/2022)

  • SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests (9/14/2022)

Safety News

COVID-19 Emergency Use Authorizations (EUAs)

COVID-19 Therapeutics

Questions? Contact the FDA’s Division of Drug Information at 301-796-3400 or [email protected]. Learn more about reporting adverse events.

Antiviral Drugs

Monoclonal Antibodies

Immune Modulators

Convalescent Plasma

Sedatives

  • Propofol-Lipuro 1%
  • Fresenius Kabi Propoven 2%

Renal Replacement Therapies

  • Regiocit replacement solution
  • Fresenius Medical multiFiltrate/ multiBic/ multiPlus replacement solutions

COVID-19 Vaccines

FDA-Approved COVID-19 Vaccines

FDA-Authorized COVID-19 Vaccines

COVID-19 Vaccine Safety

COVID-19 Tests

Test Authorizations

Testing Information

 

Email newsletter

Sign up to receive email alerts on emergency preparedness and response topics from FDA, including COVID-19, monkeypox, medical countermeasures and emerging infectious diseases.

Back to Top